Slideshow

In Case You Missed It: Psychiatric Times Psychedelics Supplement

Author(s):

Psychiatric Times Editors

Vol. 39, Issue 9 covers the latest in psychedelics research and development in psychiatry.

Related Videos
Related Content
brain
January 15th 2025

Separating the Therapeutic From the Hallucinatory: A Look at a Novel Neuroplastogen for MDD

Aaron Koenig, MD
Here's to a Psychedelic Revolution
April 9th 2022

Here's to a Psychedelic Revolution

Amir Inamdar MBBS, DNB (Psych), MFPM
Photon/Adobe Stock
December 24th 2024

Where do Psychedelics Fit in the Future of Psychiatry?

Daniel R. Karlin, MD, MA
David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders
April 6th 2021

David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders

Angela A. Coombs, MD Jennifer Sotsky, MD, MS
MindMed Reaches Phase 3 in Study of Psychedelic MM120 for Generalized Anxiety Disorder
December 17th 2024

MindMed Reaches Phase 3 in Study of Psychedelic MM120 for Generalized Anxiety Disorder

Daniel R. Karlin, MD, MA
First Patient Dosed in Phase 3 Study of Psychedelic MM120 in Generalized Anxiety Disorder
December 17th 2024

First Patient Dosed in Phase 3 Study of Psychedelic MM120 in Generalized Anxiety Disorder

Megan McSweeney
© 2025 MJH Life Sciences

All rights reserved.